Meditrial USA Inc.
7
2
2
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
14.3%
1 terminated/withdrawn out of 7 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System
Role: collaborator
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
Role: collaborator
Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy
Role: collaborator
TRICAV-II Pivotal: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation.
Role: collaborator
IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy
Role: collaborator
RITUAL Ultivision AI CADe Randomized Controlled Trial
Role: collaborator
Munich Transcatheter Mitral Valve Safety and Effectiveness
Role: collaborator
All 7 trials loaded